CA-06-FY97_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, 1-Methylcyclopropyl 4-(((5-(4-((3-(azetidin-1-yl)propyl)sulfonyl)-2-oxopiperazin-1-yl)pyrazin-2-yl)oxy)methyl)piperidine-1-carboxylate, Glucose-Dependent Insulinotropic Receptor (GDIR, GPR119) Ligands targeting GPR119 (Novartis, 57930109)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/57930109
Similar Terms
Downloads & Tools

Genes

13 genes differentially expressed following the CA-06-FY97_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
TIMM8B translocase of inner mitochondrial membrane 8 homolog B (yeast) 0.482746
RPS28 ribosomal protein S28 0.413433
S100A2 S100 calcium binding protein A2 0.296109
S100A6 S100 calcium binding protein A6 0.280457
COLEC11 collectin sub-family member 11 0.280457
RPS29 ribosomal protein S29 0.220265
RPS13 ribosomal protein S13 0.216351

decreased expression

Symbol Name Standardized Value
MEPCE methylphosphate capping enzyme -0.47783
DHRS2 dehydrogenase/reductase (SDR family) member 2 -0.380506
SEMA3F sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F -0.281026
NME1-NME2 NME1-NME2 readthrough -0.280457
SLC39A13 solute carrier family 39 (zinc transporter), member 13 -0.271935
CLU clusterin -0.204237